Rochester, NY 7/16/2009 1:03:18 AM
INSM - Insmed shares plummet on Iplex study results
Insmed Incorporated
Insmed Incorporated, INSM
WhisperFromWallStreet.com offers daily stock alerts to subscribers. Sign up for our free alerts newsletter.
Shares of Insmed Corp. plunged Thursday after the company said its drug Iplex failed to treat the most common form of muscular dystrophy in a midstage study. Shares of Insmed fell $1.24, or 54 percent to $1.09 in morning trading. The stock has traded between 32 cents and $2.57 over the last 52 weeks.
About WhisperFromWallStreet.com
WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.
Sign up for our FREE alerts newsletter at WhisperfromWallStreet.com
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
